Global RSV MRNA Vaccine Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
146
Industry
Healthcare Services
Regions
Global
Updated
April 2026

Report Overview


Report Overview
RSV mRNA Vaccine is an mRNA vaccine targeting Respiratory Syncytial Virus (RSV). RSV is a common respiratory virus that can cause cold-like symptoms and lower respiratory tract infections, particularly in infants, toddlers, and older adults. The RSV mRNA Vaccine utilizes mRNA technology to introduce mRNA sequences encoding RSV virus antigens into human cells, thereby inducing an immune response against RSV. This vaccine offers advantages such as high efficiency, safety, and ease of production, providing a new solution for preventing RSV infections. By administering the RSV mRNA Vaccine, the risk of RSV infection can be effectively reduced, related symptoms can be alleviated, and complications caused by RSV infections can be decreased.

The global RSV mRNA Vaccine market size was estimated at USD 536.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global RSV mRNA Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global RSV mRNA Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the RSV mRNA Vaccine market.
Global RSV mRNA Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abogen Bio
Innorna
Starna Therapeutics
Hualan Biological Engineering
SINOVAC
Moderna
GSK
Pfizer
Sanofi
Nanoribo
Immorna
AIM Vaccine
Shijiazhuang Pharma Group

Market Segmentation (by Type)
Base Modification Technology
m1Ψ Modification Technology

Market Segmentation (by Application)
Hospital
Clinic
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the RSV mRNA Vaccine Market
Overview of the regional outlook of the RSV mRNA Vaccine Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RSV mRNA Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of RSV mRNA Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of RSV mRNA Vaccine
    • 1.2 Key Market Segments
      • 1.2.1 RSV mRNA Vaccine Segment by Type
      • 1.2.2 RSV mRNA Vaccine Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 RSV mRNA Vaccine Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global RSV mRNA Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global RSV mRNA Vaccine Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 RSV mRNA Vaccine Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global RSV mRNA Vaccine Product Life Cycle
    • 3.3 Global RSV mRNA Vaccine Sales by Manufacturers (2020-2025)
    • 3.4 Global RSV mRNA Vaccine Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 RSV mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global RSV mRNA Vaccine Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 RSV mRNA Vaccine Market Competitive Situation and Trends
      • 3.8.1 RSV mRNA Vaccine Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest RSV mRNA Vaccine Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 RSV mRNA Vaccine Industry Chain Analysis
    • 4.1 RSV mRNA Vaccine Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of RSV mRNA Vaccine Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global RSV mRNA Vaccine Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to RSV mRNA Vaccine Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 RSV mRNA Vaccine Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
    • 6.3 Global RSV mRNA Vaccine Market Size by Type (2020-2025)
    • 6.4 Global RSV mRNA Vaccine Price by Type (2020-2025)
  • 7 RSV mRNA Vaccine Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global RSV mRNA Vaccine Market Sales by Application (2020-2025)
    • 7.3 Global RSV mRNA Vaccine Market Size (M USD) by Application (2020-2025)
    • 7.4 Global RSV mRNA Vaccine Sales Growth Rate by Application (2020-2025)
  • 8 RSV mRNA Vaccine Market Sales by Region
    • 8.1 Global RSV mRNA Vaccine Sales by Region
      • 8.1.1 Global RSV mRNA Vaccine Sales by Region
      • 8.1.2 Global RSV mRNA Vaccine Sales Market Share by Region
    • 8.2 Global RSV mRNA Vaccine Market Size by Region
      • 8.2.1 Global RSV mRNA Vaccine Market Size by Region
      • 8.2.2 Global RSV mRNA Vaccine Market Size by Region
    • 8.3 North America
      • 8.3.1 North America RSV mRNA Vaccine Sales by Country
      • 8.3.2 North America RSV mRNA Vaccine Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe RSV mRNA Vaccine Sales by Country
      • 8.4.2 Europe RSV mRNA Vaccine Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific RSV mRNA Vaccine Sales by Region
      • 8.5.2 Asia Pacific RSV mRNA Vaccine Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America RSV mRNA Vaccine Sales by Country
      • 8.6.2 South America RSV mRNA Vaccine Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa RSV mRNA Vaccine Sales by Region
      • 8.7.2 Middle East and Africa RSV mRNA Vaccine Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 RSV mRNA Vaccine Market Production by Region
    • 9.1 Global Production of RSV mRNA Vaccine by Region(2020-2025)
    • 9.2 Global RSV mRNA Vaccine Revenue Market Share by Region (2020-2025)
    • 9.3 Global RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America RSV mRNA Vaccine Production
      • 9.4.1 North America RSV mRNA Vaccine Production Growth Rate (2020-2025)
      • 9.4.2 North America RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe RSV mRNA Vaccine Production
      • 9.5.1 Europe RSV mRNA Vaccine Production Growth Rate (2020-2025)
      • 9.5.2 Europe RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan RSV mRNA Vaccine Production (2020-2025)
      • 9.6.1 Japan RSV mRNA Vaccine Production Growth Rate (2020-2025)
      • 9.6.2 Japan RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China RSV mRNA Vaccine Production (2020-2025)
      • 9.7.1 China RSV mRNA Vaccine Production Growth Rate (2020-2025)
      • 9.7.2 China RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Abogen Bio
      • 10.1.1 Abogen Bio Basic Information
      • 10.1.2 Abogen Bio RSV mRNA Vaccine Product Overview
      • 10.1.3 Abogen Bio RSV mRNA Vaccine Product Market Performance
      • 10.1.4 Abogen Bio Business Overview
      • 10.1.5 Abogen Bio SWOT Analysis
      • 10.1.6 Abogen Bio Recent Developments
    • 10.2 Innorna
      • 10.2.1 Innorna Basic Information
      • 10.2.2 Innorna RSV mRNA Vaccine Product Overview
      • 10.2.3 Innorna RSV mRNA Vaccine Product Market Performance
      • 10.2.4 Innorna Business Overview
      • 10.2.5 Innorna SWOT Analysis
      • 10.2.6 Innorna Recent Developments
    • 10.3 Starna Therapeutics
      • 10.3.1 Starna Therapeutics Basic Information
      • 10.3.2 Starna Therapeutics RSV mRNA Vaccine Product Overview
      • 10.3.3 Starna Therapeutics RSV mRNA Vaccine Product Market Performance
      • 10.3.4 Starna Therapeutics Business Overview
      • 10.3.5 Starna Therapeutics SWOT Analysis
      • 10.3.6 Starna Therapeutics Recent Developments
    • 10.4 Hualan Biological Engineering
      • 10.4.1 Hualan Biological Engineering Basic Information
      • 10.4.2 Hualan Biological Engineering RSV mRNA Vaccine Product Overview
      • 10.4.3 Hualan Biological Engineering RSV mRNA Vaccine Product Market Performance
      • 10.4.4 Hualan Biological Engineering Business Overview
      • 10.4.5 Hualan Biological Engineering Recent Developments
    • 10.5 SINOVAC
      • 10.5.1 SINOVAC Basic Information
      • 10.5.2 SINOVAC RSV mRNA Vaccine Product Overview
      • 10.5.3 SINOVAC RSV mRNA Vaccine Product Market Performance
      • 10.5.4 SINOVAC Business Overview
      • 10.5.5 SINOVAC Recent Developments
    • 10.6 Moderna
      • 10.6.1 Moderna Basic Information
      • 10.6.2 Moderna RSV mRNA Vaccine Product Overview
      • 10.6.3 Moderna RSV mRNA Vaccine Product Market Performance
      • 10.6.4 Moderna Business Overview
      • 10.6.5 Moderna Recent Developments
    • 10.7 GSK
      • 10.7.1 GSK Basic Information
      • 10.7.2 GSK RSV mRNA Vaccine Product Overview
      • 10.7.3 GSK RSV mRNA Vaccine Product Market Performance
      • 10.7.4 GSK Business Overview
      • 10.7.5 GSK Recent Developments
    • 10.8 Pfizer
      • 10.8.1 Pfizer Basic Information
      • 10.8.2 Pfizer RSV mRNA Vaccine Product Overview
      • 10.8.3 Pfizer RSV mRNA Vaccine Product Market Performance
      • 10.8.4 Pfizer Business Overview
      • 10.8.5 Pfizer Recent Developments
    • 10.9 Sanofi
      • 10.9.1 Sanofi Basic Information
      • 10.9.2 Sanofi RSV mRNA Vaccine Product Overview
      • 10.9.3 Sanofi RSV mRNA Vaccine Product Market Performance
      • 10.9.4 Sanofi Business Overview
      • 10.9.5 Sanofi Recent Developments
    • 10.10 Nanoribo
      • 10.10.1 Nanoribo Basic Information
      • 10.10.2 Nanoribo RSV mRNA Vaccine Product Overview
      • 10.10.3 Nanoribo RSV mRNA Vaccine Product Market Performance
      • 10.10.4 Nanoribo Business Overview
      • 10.10.5 Nanoribo Recent Developments
    • 10.11 Immorna
      • 10.11.1 Immorna Basic Information
      • 10.11.2 Immorna RSV mRNA Vaccine Product Overview
      • 10.11.3 Immorna RSV mRNA Vaccine Product Market Performance
      • 10.11.4 Immorna Business Overview
      • 10.11.5 Immorna Recent Developments
    • 10.12 AIM Vaccine
      • 10.12.1 AIM Vaccine Basic Information
      • 10.12.2 AIM Vaccine RSV mRNA Vaccine Product Overview
      • 10.12.3 AIM Vaccine RSV mRNA Vaccine Product Market Performance
      • 10.12.4 AIM Vaccine Business Overview
      • 10.12.5 AIM Vaccine Recent Developments
    • 10.13 Shijiazhuang Pharma Group
      • 10.13.1 Shijiazhuang Pharma Group Basic Information
      • 10.13.2 Shijiazhuang Pharma Group RSV mRNA Vaccine Product Overview
      • 10.13.3 Shijiazhuang Pharma Group RSV mRNA Vaccine Product Market Performance
      • 10.13.4 Shijiazhuang Pharma Group Business Overview
      • 10.13.5 Shijiazhuang Pharma Group Recent Developments
  • 11 RSV mRNA Vaccine Market Forecast by Region
    • 11.1 Global RSV mRNA Vaccine Market Size Forecast
    • 11.2 Global RSV mRNA Vaccine Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe RSV mRNA Vaccine Market Size Forecast by Country
      • 11.2.3 Asia Pacific RSV mRNA Vaccine Market Size Forecast by Region
      • 11.2.4 South America RSV mRNA Vaccine Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of RSV mRNA Vaccine by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global RSV mRNA Vaccine Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of RSV mRNA Vaccine by Type (2026-2035)
      • 12.1.2 Global RSV mRNA Vaccine Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of RSV mRNA Vaccine by Type (2026-2035)
    • 12.2 Global RSV mRNA Vaccine Market Forecast by Application (2026-2035)
      • 12.2.1 Global RSV mRNA Vaccine Sales (K MT) Forecast by Application
      • 12.2.2 Global RSV mRNA Vaccine Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.